| 标题 |
 GS-010 Outcomes of 48 weeks of therapy and subsequent 24-week post-treatment period with tobevibart (VIR-3434) and elebsiran (VIR-2218) with or without pegylated interferon alfa-2a in chronic hepatitis B virus infection. Findings from the MARCH study |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Hepatology 作者：Edward Gane; Kosh Agarwal; Jeong Heo; Alina Jucov; Young‐Suk Lim; et al 出版日期：2025-05-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
DW
GingerF
老的火龙果
斯文的白玉
渡人舟
anugraphics
Ali
嘻嘻哈哈
12Nightz
Nole
无极微光
tang
温暖的炒饭
自信紫夏
Rita
cdercder
coolru
潇洒的早晨
飞天三叉戟
皖公网安备34019202002308
